NEW YORK (360Dx) – Medicortex Finland announced on Tuesday a deal with Pro-Lab Diagnostics aimed at commercializing Medicortex's brain injury detection kit in Canada and the UK.

Under the terms of the agreement Pro-Lab will shepherd the kit through the regulatory processes in Canada and the UK, as well as be responsible for clinical validation of the kit. Medicortex has granted Pro-Lab exclusive rights to sell the test in Canada and the UK in return for royalties.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.